curasafehealthcare.com
  • Home
  • About
  • Services
  • Therapeutic Areas
  • Careers
  • Latest News
  • Contact Us
Select Page

Counterpain PXM Versus Diclofenac Versus Piroxicam

by palligoelme@gmail.com | Mar 16, 2026 | Clinical Trials

​ Conditions: Ankle Sprain; Back Pain; Osteoarthritis (OA) of the Knee; Tennis Elbow; Runner’s Knee Interventions: Drug: Piroxicam plus Counterirritant (brand name Counterpain® PXM).; Drug: Diclofenac Sodium 10 mg (Brand Name Hotin® DCL); Drug: Piroxicam 0.5%...

Fully Human Bispecific Anti-CD20, Anti-CD19 CAR T Cells for Patients With Relapsed and/or Refractory B Cell Malignancies

by palligoelme@gmail.com | Mar 13, 2026 | Clinical Trials

​ Conditions: B-cell Non Hodgkin Lymphoma Interventions: Biological: 1 X 10^6 cells/kg; Biological: 2.5 X 10^6 cells/kg; Biological: Dose expansion: The maximum tolerated dose of CAR-T cells Sponsors: Medical College of Wisconsin Not yet recruiting Conditions: B-cell...

Effects of an Aerobic Exercise Program on Cardiovascular Risk in Patients With Chronic Kidney Disease or Rheumatoid Arthritis

by palligoelme@gmail.com | Mar 13, 2026 | Clinical Trials

​ Conditions: Aerobic Exercise; Rhumatoid Arthisis; Chronic Kidney Disease; Cardiovascular (CV) Risk Interventions: Behavioral: Aerobic exercise program; Behavioral: Therapeutic education Sponsors: Jérôme Bouchan; UMR1098, EFS BFC, BESANCON; Centre Hospitalier...

Mobile Shared Decision-Making Program for ICU Caregivers

by palligoelme@gmail.com | Mar 13, 2026 | Clinical Trials

​ Conditions: Terminally Ill Patients Interventions: Other: Experimental: Mobile technology devices; Other: Placebo Comparator: Placebo Sponsors: CHIA-HUI MA; Mackay Memorial Hospital Completed Conditions: Terminally Ill Patients Interventions: Other: Experimental:...

Survival Without Persistent Limiting Toxicity: Real Life Prospective Cohort of Advanced Neuroendocrine Tumor

by palligoelme@gmail.com | Mar 13, 2026 | Clinical Trials

​ Conditions: Neuroendocrine (NE) Tumors Interventions: Other: quality of life questionnaire, treatment side effect follow up Sponsors: Gustave Roussy, Cancer Campus, Grand Paris Not yet recruiting Conditions: Neuroendocrine (NE) Tumors Interventions: Other: quality...
« Older Entries
Next Entries »

Recent Posts

  • Peer-led, Mobile App Supported Linkage to Opioid Use Disorder Treatment
  • Effects of Scapular Training on Adolescent Boxers
  • Endotracheal Tube Versus Transcartilage Needle Electrodes for Nerve Monitoring in Thyroid Surgery
  • A Study to Learn How Different Amounts of the Study Medicine Called PF-08161842 Are Tolerated and Act in the Body in Healthy and Older Adults
  • Comparing the Efficacy of a Conversational Agent (QuitBot) Versus Standard Health Education on Smoking Cessation Among Medical Students; A Randomized Controlled Trial.

Recent Comments

No comments to show.

Curasafe healthcare solutions Pvt. Ltd. provides comprehensive services including safety program oversight, risk management, and regulatory compliance.

Important Links

  • Home
  • Contact Us
Connect With Us

Contact


711, Shivalik Satyamev, Bopal Ambli Junction, Bopal, Ahmedabad, Daskroi, Gujarat, India, 380058.


info@curasafehealthcare.com



(+91) 97803 81065

Copyright © 2025 Curasafehealthcare ®